Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II... see more

Bullboard (TSX:BCT)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next
Post by LondonInveston Apr 29, 2022 5:52am

BCTX To Quickly Regain $8/share

Short-tem, BCTX should quickly regain $8/share to keep the 50-DMA rising and above the 200-DMA.  Very bullish here.  Short-term this will add confidence the recent decline has put in another ...more  
249
Discussion
Comment by HomerAndCompanyon Apr 14, 2022 8:42am

RE:BCTX Fast Track FDA Approval

Sell off on great news after a run-up on no news!? What's going on? -TIA
140
Discussion
Post by LondonInveston Apr 13, 2022 8:12am

BCTX Fast Track FDA Approval

Well this week's options trading isn't at all suspicious!  I am long so happy about great advancement for company on outstanding news, but someone definitely leaked something for all ...more  
247
Discussion
Post by LondonInveston Apr 12, 2022 1:31pm

Not Puts Being Exercised

Today's action in BCTX is being postulated as PUTS being exercise, but this does not explain the massive purchasing of CALLS all day.  Now it is 12,512 contracts for April 14, 2022 Strike $12 ...more  
158
Post by LondonInveston Apr 12, 2022 1:27pm

1.1M Options Shares Bought 2 Days Left

Today, BCTX prior to its poster presentation this afternoon has had volatile trading moving around 20% with over 3 million shares traded.  More interesting, there have been 11,000 contracts for ...more  
149
Post by LondonInveston Mar 25, 2022 7:39am

Potential for this company - 10x ($100+/share)

I have bought BCTX aggressively because it is a very undervalued company for it's potential value in its research.  I have been trying to calculate what potential value is if their tech ...more  
261
Post by LondonInveston Mar 22, 2022 3:54pm

Massive Short Squeeze Possible Above $10.50

Facts: Currently about 15% of the outstandind shares of BCTX are shorted. Taking into account the tightly held shares by institutions and insider holdings the short position is closer to 40% of float ...more  
167
Post by LondonInveston Mar 22, 2022 10:20am

Likely Trend Up For Break Away Gap

This is just speculation, but the chart action in BCTX is very encouraging going into the AACR on April 12, 2022.  I expect it to continue to rise into the $10-$11 range and build a higher base.& ...more  
147
Post by LondonInveston Mar 17, 2022 3:40pm

Keytruda Lung Cancer Reduction, Good News for BCTX Study

Merck just released results for their Keytruda Lung cancer study and it showed a 24% reduction in disease recurrence or death.  Good news for Briacell as this is one of the new therapeutic ...more  
174
Post by LondonInveston Mar 17, 2022 9:36am

No gaps in chart, short interest still high, Lassonde Curve

From a technical perspective it is nice to see BCTX trading in ranges everyday to keep chart tight and clean.  I am not a fan of gap ups as they are filled usually.  A breakaway gap on an ...more  
128
Post by LondonInveston Mar 17, 2022 6:28am

Merck potential bidder for Briacell

Merck as potential bidder for Briacell makes strategic sense: 1)  Merck was already a partner in study with Briacell with their drug Keytruda 2)  Keytruda sales will be $17 billion in 2022 ...more  
166
Post by LondonInveston Mar 17, 2022 5:59am

Briacell Presentation Potential Multi-Billion Dollar Value

Dr. William Williams discussing Briacell and what to expect in 2022.  At 13:30 in video he discusses a revaluation and potential for multi-billion dollar valuation. https://www.youtube.com/watch ...more  
149
Post by tobias1738on Jan 05, 2022 12:18pm

BriaCell Therapeutics corp HLA scores success

https://scr.zacks.com/news/news-details/2022/BCTX-Game-Set-and-Match-HLAs-Score-Success/default.aspx
116
Post by James72on Dec 02, 2021 10:47am

Warrants

Given the payoff profiles if you want exposure to BCTX the warrants look extremely cheap vs the stock itself.
161
Post by Goldnboy1on Oct 05, 2021 2:05am

29.83

This is how many shares you would get of $APC for every one share of $BCT. One and only post. Just spreading the love. Not a spammer. Just a serially successful VC tossing you guys some early stage ...more  
293
Prev 1 2 3 4 5 6 7 8 9 10 11 12 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities